Literature DB >> 20587736

Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function.

Susan Sienko Thomas1, Cathleen E Buckon, Alina Nicorici, Anita Bagley, Craig M McDonald, Michael D Sussman.   

Abstract

Corticosteroids have recently been shown to reduce expected loss of muscle strength in patients with Duchenne muscular dystrophy and extend the time they can walk. We evaluated 43 boys with the condition to determine whether taking corticosteroids is associated with differences in gait pattern, gross motor skills, energy efficiency, and timed motor performance. We used the gait deviation index to quantify the degree of gait pathology and a single measure of gait quality. There were minimal differences in gait pattern, gross motor skills, energy efficiency, or timed motor performance in boys who took corticosteroids compared with those who did not. Clustering by gait deviation index, however, revealed subtle differences between groups in gait patterns, gross motor skills, and energy efficiency. We conclude that, in boys with Duchenne muscular dystrophy, gait pattern deviations are related to function, which can provide further insight into the understanding of disease progression and treatment options to enhance function and maintain ambulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587736      PMCID: PMC3794706          DOI: 10.1177/0883073810371002

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy.

Authors:  G T Carter; C M McDonald
Journal:  Am J Phys Med Rehabil       Date:  2000 Sep-Oct       Impact factor: 2.159

2.  Comparison of oxygen consumption measurements in children with cerebral palsy to children with muscular dystrophy.

Authors:  T R Bowen; F Miller; W Mackenzie
Journal:  J Pediatr Orthop       Date:  1999 Jan-Feb       Impact factor: 2.324

3.  Correlation between the gross motor function measure scores and gait spatiotemporal measures in children with neurological impairments.

Authors:  L M Drouin; F Malouin; C L Richards; S Marcoux
Journal:  Dev Med Child Neurol       Date:  1996-11       Impact factor: 5.449

4.  Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.

Authors:  Birol Balaban; Dennis J Matthews; Gerald H Clayton; Terri Carry
Journal:  Am J Phys Med Rehabil       Date:  2005-11       Impact factor: 2.159

Review 5.  Duchenne muscular dystrophy.

Authors:  Michael Sussman
Journal:  J Am Acad Orthop Surg       Date:  2002 Mar-Apr       Impact factor: 3.020

6.  Determination of gait patterns in children with spastic diplegic cerebral palsy using principal components.

Authors:  Alessandra Carriero; Amy Zavatsky; Julie Stebbins; Tim Theologis; Sandra J Shefelbine
Journal:  Gait Posture       Date:  2008-08-03       Impact factor: 2.840

7.  Use of cluster analysis for gait pattern classification of patients in the early and late recovery phases following stroke.

Authors:  Sara Mulroy; JoAnne Gronley; Walt Weiss; Craig Newsam; Jacquelin Perry
Journal:  Gait Posture       Date:  2003-08       Impact factor: 2.840

Review 8.  Gait and posture changes in the Duchenne muscular dystrophy child.

Authors:  J D Hsu; J Furumasu
Journal:  Clin Orthop Relat Res       Date:  1993-03       Impact factor: 4.176

9.  Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.

Authors:  W D Biggar; V A Harris; L Eliasoph; B Alman
Journal:  Neuromuscul Disord       Date:  2006-03-20       Impact factor: 4.296

10.  The pathomechanics of gait in Duchenne muscular dystrophy.

Authors:  D H Sutherland; R Olshen; L Cooper; M Wyatt; J Leach; S Mubarak; P Schultz
Journal:  Dev Med Child Neurol       Date:  1981-02       Impact factor: 5.449

View more
  19 in total

1.  A novel ex vivo protocol to mimic human walking gait: implications for Duchenne muscular dystrophy.

Authors:  Katherine E Bukovec; Xiao Hu; Matthew Borkowski; Duane Jeffery; Silvia S Blemker; Robert W Grange
Journal:  J Appl Physiol (1985)       Date:  2020-09-03

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Relationship between the climbing up and climbing down stairs domain scores on the FES-DMD, the score on the Vignos Scale, age and timed performance of functional activities in boys with Duchenne muscular dystrophy.

Authors:  Lilian A Y Fernandes; Fátima A Caromano; Silvana M B Assis; Michele E Hukuda; Mariana C Voos; Eduardo V Carvalho
Journal:  Braz J Phys Ther       Date:  2014 Nov-Dec       Impact factor: 3.377

4.  Longitudinal Alterations in Gait Features in Growing Children With Duchenne Muscular Dystrophy.

Authors:  Ines Vandekerckhove; Marleen Van den Hauwe; Nathalie De Beukelaer; Elze Stoop; Marije Goudriaan; Margaux Delporte; Geert Molenberghs; Anja Van Campenhout; Liesbeth De Waele; Nathalie Goemans; Friedl De Groote; Kaat Desloovere
Journal:  Front Hum Neurosci       Date:  2022-06-02       Impact factor: 3.473

5.  Gait characteristics in a canine model of X-linked myotubular myopathy.

Authors:  Melissa A Goddard; Emily Burlingame; Alan H Beggs; Anna Buj-Bello; Martin K Childers; Anthony P Marsh; Valerie E Kelly
Journal:  J Neurol Sci       Date:  2014-08-29       Impact factor: 3.181

6.  Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring.

Authors:  Jin-Hong Shin; Brian Greer; Chady H Hakim; Zhongna Zhou; Yu-chia Chung; Ye Duan; Zhihai He; Dongsheng Duan
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

7.  Gait disturbances in dystrophic hamsters.

Authors:  Thomas G Hampton; Ajit Kale; Ivo Amende; Wenlong Tang; Scott McCue; Hemmi N Bhagavan; Case G VanDongen
Journal:  J Biomed Biotechnol       Date:  2011-01-13

8.  Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophy.

Authors:  Merel-Anne Brehm; Jiska C E Kempen; Anneke J van der Kooi; Imelda J M de Groot; Janneke C van den Bergen; Jan J G M Verschuuren; Erik H Niks; Jaap Harlaar
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

9.  The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart W Peltz
Journal:  Muscle Nerve       Date:  2013-07-17       Impact factor: 3.217

10.  Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy.

Authors:  Juliette Ropars; Mathieu Lempereur; Carole Vuillerot; Vincent Tiffreau; Sylviane Peudenier; Jean-Marie Cuisset; Yann Pereon; Fabien Leboeuf; Ludovic Delporte; Yannick Delpierre; Raphaël Gross; Sylvain Brochard
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.